Matthew Smith
Nurse Practitioner · Akron, OHNPI 1811515521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 45.5% of the total. 2025 is the largest year on record at $932, 2.0 times the $459 reported in 2021. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$1K
- Neurocrine Biosciences, Inc.$535
- Validus Pharmaceuticals LLC$262
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$249
- AbbVie$154
- Daiichi Sankyo Inc.$74
- plus $393 from 11 others
What the payments were for
- Food & beverage$3,01398%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 134 | $1,393 |
| Neurocrine Biosciences, Inc. | 15 | $535 |
| Validus Pharmaceuticals LLC | 3 | $262 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $249 |
| AbbVie | 13 | $154 |
| Daiichi Sankyo Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Seagen Inc. | 3 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Neuronetics, Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Adlon Therapeutics L.p. | 2 | $28 |
| Corium, LLC | 1 | $19 |
| Indivior Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,059 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atomoxetine Hcl | 13 | $2,941 |
| Aripiprazole | 16 | $1,852 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 12 | $1,032 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $785 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 32 | $692 |
| Duloxetine Hcl | 20 | $684 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $491 |
| Lithium Carbonate ErLithium Carbonate | 12 | $350 |
| Lamotrigine | 26 | $344 |
| Trazodone Hcl | 31 | $261 |
| Quetiapine Fumarate | 26 | $257 |
| Bupropion XlBupropion Hcl | 11 | $159 |
| Prazosin Hcl | 13 | $145 |
| Mirtazapine | 13 | $116 |
| Fluoxetine Hcl | 23 | $84 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Akron
- Sara GraterAkron$23K
- Julia GoldenAkron$11K
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.